These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 1587538)

  • 1. Controlled-release vaccines--biodegradable polylactide/polyglycolide (PL/PG) microspheres as antigen vehicles.
    Aguado MT; Lambert PH
    Immunobiology; 1992 Feb; 184(2-3):113-25. PubMed ID: 1587538
    [No Abstract]   [Full Text] [Related]  

  • 2. [Long-term immunogenicity and immunologic priming of animals to pulsed controlled-release system for tetanus toxoid vaccine delivery].
    He Y; Chen ZH; Wei SL
    Yao Xue Xue Bao; 2001 Sep; 36(9):695-8. PubMed ID: 12580111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies for stabilising tetanus toxoid towards the development of a single-dose tetanus vaccine.
    Schwendeman SP; Costantino HR; Gupta RK; Tobio M; Chang AC; Alonso MJ; Siber GR; Langer R
    Dev Biol Stand; 1996; 87():293-306. PubMed ID: 8854030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of the immune response to tetanus toxoid by polylactide-polyglycolide microspheres.
    Walker KB; Xing DK; Sesardic D; Corbel MJ
    Dev Biol Stand; 1998; 92():259-67. PubMed ID: 9554281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microencapsulation of antigens using biodegradable polyesters: facts and phantasies.
    Kissel T; Koneberg R; Hilbert AK; Hungerer KD
    Behring Inst Mitt; 1997 Feb; (98):172-83. PubMed ID: 9382738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of an animal model to assess the immunogenicity of single-dose tetanus and diphtheria vaccines based on controlled release from biodegradable polymer microspheres.
    Gupta RK; Griffin P; Rivera R; Siber GR
    Dev Biol Stand; 1998; 92():277-87. PubMed ID: 9554282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A long acting biodegradable controlled delivery of chitosan microspheres loaded with tetanus toxoide as model antigen.
    Varma S; Sadasivan C
    Biomed Pharmacother; 2014 Mar; 68(2):225-30. PubMed ID: 24051124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Controlled release antigen from the injection site--new model for a single-shot vaccination?].
    Gałazka A; Wysokińska T
    Postepy Hig Med Dosw; 1998; 52(2):157-72. PubMed ID: 9640979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of antigenic tetanus toxoid extracted from biodegradable microspheres.
    Xing DK; McLellan K; Corbel MJ; Sesardic D
    Biologicals; 1996 Mar; 24(1):57-65. PubMed ID: 8733602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Homeostasis indexes of staphylococcal anatoxin immunized blood donors, previously immunized with tetanus toxoid].
    Fedorovs'ka OO; Nazarchuk LV; Skachkova NK; Nemyrovs'ka LN
    Fiziol Zh (1994); 2001; 47(4):58-62. PubMed ID: 11571925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Future approaches to vaccine development: single-dose vaccines using controlled-release delivery systems.
    Aguado MT
    Vaccine; 1993; 11(5):596-7. PubMed ID: 8488720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biodegradable polymer microspheres as vaccine adjuvants and delivery systems.
    Gupta RK; Chang AC; Siber GR
    Dev Biol Stand; 1998; 92():63-78. PubMed ID: 9554260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulsed controlled-released system for potential use in vaccine delivery.
    Sanchez A; Gupta RK; Alonso MJ; Siber GR; Langer R
    J Pharm Sci; 1996 Jun; 85(6):547-52. PubMed ID: 8773947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and evaluation of chitosan microspheres for tetanus, diphtheria and divalent vaccines: a comparative study of subcutaneous and intranasal administration in mice.
    Hashem FM; Fahmy SA; El-Sayed AM; Al-Sawahli MM
    Pharm Dev Technol; 2013; 18(5):1175-85. PubMed ID: 21985525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single dose vaccine based on biodegradable polyanhydride microspheres can modulate immune response mechanism.
    Kipper MJ; Wilson JH; Wannemuehler MJ; Narasimhan B
    J Biomed Mater Res A; 2006 Mar; 76(4):798-810. PubMed ID: 16345084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biodegradable microspheres of poly(DL-lactic acid) containing piroxicam as a model drug for controlled release via the parenteral route.
    Lalla JK; Sapna K
    J Microencapsul; 1993; 10(4):449-60. PubMed ID: 8263674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunogenecity and antigenic properties of staphylococcal toxoid and vaccine in laboratory animals. I. Staphylococcal toxoid].
    Wysokìnska T; Albrycht H
    Med Dosw Mikrobiol; 1973; 25(3):193-204. PubMed ID: 4760222
    [No Abstract]   [Full Text] [Related]  

  • 18. Xenobiotic polymers as vaccine vehicles.
    Payne LG; Jenkins SA; Andrianov A; Langer R; Roberts BE
    Adv Exp Med Biol; 1995; 371B():1475-80. PubMed ID: 7502840
    [No Abstract]   [Full Text] [Related]  

  • 19. Encapsulation of proteins and peptides into biodegradable poly(D,L-lactide-co-glycolide) microspheres prolongs and enhances antigen presentation by human dendritic cells.
    Waeckerle-Men Y; Allmen EU; Gander B; Scandella E; Schlosser E; Schmidtke G; Merkle HP; Groettrup M
    Vaccine; 2006 Mar; 24(11):1847-57. PubMed ID: 16288821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly(D,L-lactic-co-glycolic acid) versus chitosan microspheres.
    Jaganathan KS; Rao YU; Singh P; Prabakaran D; Gupta S; Jain A; Vyas SP
    Int J Pharm; 2005 Apr; 294(1-2):23-32. PubMed ID: 15814228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.